James C. Lin
Lawyers
Filters
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
Ocumension Therapeutics HK$793.8 million top-up placement of shares
We advised the placing agent in connection with the equity offering
Innovent Biologics HK$4.73 billion placement of shares
We advised the joint placing agents in connection with the equity offering
Kuke Music Holding $50 million IPO and NYSE listing
We advised the underwriters on the IPO of ADSs
Provident Acquisition $230 million IPO
We advised Provident, a SPAC, on its IPO and Nasdaq listing
Gracell Biotechnologies $209 million IPO and Nasdaq listing
We advised the underwriters on the IPO of ADSs
iQIYI $1.5 billion concurrent convertible notes and equity offerings
Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by iQIYI, Inc. of $800 million aggregate principal amount of its 4.00%…
Antengene HK$2.79 billion IPO
Davis Polk advised Antengene Corporation Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…
Baidu $950 million notes offering
Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of its $650 million 1.720% notes due 2026 and $300 million 2.375% notes due 2030.
Baidu, Inc. is a leading…
Kingsoft Cloud Holdings $509 million follow-on offering of ADSs
Davis Polk advised Kingsoft Cloud Holdings Limited and certain selling shareholders on its approximately $509 million SEC-registered follow-on public offering of 16,421,576 American…